Actively Recruiting
Study of Subthreshold Micropulse Laser Treatment for Central Serous Chorioretinopathy to Evaluate Eye Recovery and Function
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-09-23
36
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying changes in the choroid and choriocapillaris layers of the eye in patients with central serous chorioretinopathy CSC who have undergone subthreshold micropulse laser treatment. This evaluation follows any improvement observed after conservative treatments using Acetazolamide andor Eplerenone. The study aims to better understand the morphological and functional recovery in these patients. The treatment being studied is subthreshold micropulse laser therapy, which involves applying 33 laser spots of 100 microns each, spaced 2.5 microns apart, with a duration of 200 seconds and a power of 250 milliwatts at a 5% duty cycle. This observational study follows patients who have not responded to initial conservative therapy and have persistent foveal serous retinal detachment for at least six months. Participants will be monitored at 12 and 24 months after treatment for various outcomes including vessel density changes, choroidal thickness, retinal function, and quality of life. Assessments include imaging tests like optical coherence tomography, fluorescein angiography, and indocyanine green angiography, as well as evaluations of visual acuity and metamorphopsia. The study tracks these measures to assess the recovery and effects of the laser treatment over time.
CONDITIONS
Brief Title
Central Serous Chorioretinopathy and Micropulse Laser Treatment
Research Team
M
Maria Cristina Savastano, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here